Background: Multidrug resistance has become a quandary in the treatment of bacterial infections. The effect of resistance mutations and the fitness cost on the pathogenicity of Pseudomonas aeruginosa is not well established. The objective of this study was to examine the impact of multidrug resistance on the fitness and virulence of P. aeruginosa.
Introduction
Pseudomonas aeruginosa is an opportunistic pathogen that causes nosocomial infections in humans, including bacteraemia, as well as urinary and respiratory tract infections. 1 Important risk groups include critically ill and immunocompromised patients. The mortality rate due to P. aeruginosa bacteraemia may be as high as 50% -60%. 2, 3 The high mortality rate is attributed to the many challenges in the treatment of P. aeruginosa infections. One challenge is the intrinsic resistance of P. aeruginosa to a wide range of antibiotics due to the low permeability of its outer membrane as well as the abundance of drug efflux systems. 4, 5 Additionally P. aeruginosa has a remarkable capacity to acquire resistance to almost all drugs available commercially (including b-lactams, aminoglycosides and fluoroquinolones) through multiple mechanisms. 6, 7 Hocquet et al. 8 examined 120 bacteraemia isolates of P. aeruginosa that were recovered from 119 patients admitted to six hospitals between 1999 and 2004. They observed that 75% of the P. aeruginosa bloodstream isolates showed a non-wild-type susceptibility profile to antibiotics, with at least a 4-fold elevation in the MIC compared with the molecular reference strain PAO1. 8 Mechanisms that contribute to the resistance of P. aeruginosa to b-lactams include up-regulation of intrinsic AmpC b-lactamase, over-expression of multidrug efflux pumps (e.g. MexAB-OprM, MexCD-OprJ and MexEF-OprN systems) and reduction of outer membrane permeability through the loss of OprD porin. 9 Production of aminoglycoside or 16S rRNA modifying enzymes and over-expression of the MexXY-OprM multidrug efflux pump confer resistance to the aminoglycosides. 10 Resistance to fluoroquinolones is acquired via mutations in target genes (gyrA and gyrB subunits of topoisomerase II, and the parC and parE subunits of topoisomerase IV) or through over-expression of multidrug efflux pumps. 8, 9 The effect of resistance mutations on bacterial fitness and virulence is a topic of increasing interest. Previous studies on Salmonella typhimurium showed that multidrug-resistant (MDR) mutants were avirulent in mice. 11 However, the avirulent resistant mutants rapidly accumulated multiple compensatory mutations that restored virulence without affecting the level of resistance. 11 Several studies have shown that fitness costs of resistance mutations are affected by both environmental and epistatic effects. 12 Streptomycin resistance caused by mutations in K42N and P90S in 30S ribosomal S12 protein (rpsL gene) in Salmonella enterica subsp. enterica serovar Typhimurium resulted in impaired growth on rich medium. 13 However, the resistant mutants were able to grow faster than the wild-type strains on poorer carbon sources. This was attributed to failure of the resistant mutants to induce the stress-inducible RNA polymerase s-factor (s S ). On the other hand, induction of s S in the wild-type isolates resulted in a reduced growth rate. Komp Lindgren et al.
14 studied the effect of accumulation of multiple norfloxacin resistance mutations (such as alterations in DNA gyrase, topoisomerase IV and AcrAB-TolC mediated efflux) on the fitness of Escherichia coli. In that study, single mutations were not associated with a significant fitness cost. However, accumulation of three or more resistance mutations was associated with a large reduction in fitness of the resistant mutants, both in vitro and in vivo. Schulz zur Wiesch et al. 15 developed a mathematical model to better understand how compensatory mutations affect bacterial fitness in the absence and presence of treatment. They found that when a resistance mutation was accompanied by a high fitness cost, it had to be very efficient in suppressing (overcoming) the treatment effect. On the other hand, fitness compensation allowed survival of bacteria at a lower efficiency of resistance mutations. Compensation of fitness could be acquired through several mechanisms. 12 For example, compensatory mutations could act to restore the efficiency of the function affected by the resistance mutation. 11, 16 Also, compensatory resistance mutations could result in a reversion to the wild-type genotype (gene conversion) 17 or alteration of the fitness of the resistant phenotype through gene amplification. 18 In this study we examined the effect of acquisition of (single and multiple) resistance mechanisms on the fitness and virulence of P. aeruginosa. Our hypothesis was that acquiring resistance mutations would impair the ability of the bacterium to develop stress adaptation mechanisms, resulting in reduced survival under suboptimal growth conditions, such as in an animal host or in a nutrient-limited environment. Moreover, the virulence of different P. aeruginosa strains was compared using a murine pneumonia model.
Materials and methods

Bacteria
We used 14 different strains of P. aeruginosa in this study. The origins and known resistance mechanisms of these strains are described in Table 1 . The genetic mutant strains were constructed by in-frame deletion and the mechanisms of resistance were demonstrated using methods previously reported. 19, 20 The clinical isolates were obtained from the clinical microbiology laboratory of St. Luke's Episcopal Hospital, Houston, TX, USA. 21, 22 The isolates were stored in Protect w (Key Scientific Products, Abdelraouf et al.
Round Rock, TX, USA) storage vials at 2708C. Prior to each experiment, the isolates were subcultured at least twice on 5% blood agar plates.
Animals
Immunocompetent female Swiss-Webster mice (21 -26 g) (Harlan, Indianapolis, IN, USA) were used. The mice received food and water ad libitum. All animals were cared for in accordance with the highest humane and ethical standards, as approved by the Institutional Animal Care and Use Committee of the University of Houston.
In vitro growth rates determination
Overnight cultures of the isolates were inoculated in 10 mL of cation-adjusted Mueller-Hinton broth (MHB) (BBL, Sparks, MD, USA) and incubated with continuous shaking at 378C. In the first study, the cultures were diluted based on absorbance at 630 nm to an inoculum of approximately 10 5 cfu/mL in 20 mL of full-strength MHB. In the second study, the cultures were diluted to achieve the same inoculum, but in 0.25-strength MHB. The cultures were further incubated with shaking at 378C for 24 h. Serial samples (500 mL) were obtained in triplicate at different timepoints (0, 1, 2, 3, 4, 6, 8, and 24 h) to determine the bacterial density (cfu/mL); serial 10-fold dilutions of the samples in 0.9% saline solution were plated (50 mL) onto Mueller-Hinton agar (MHA) plates (Hardy Diagnostics, Santa Maria, CA, USA). The plates were incubated for 24 h at 358C and then the colonies were enumerated. The ADAPT II program 23 was used to analyse the time-growth profiles and to derive the growth rates for the isolates. The model that was fitted to the bacterial burden-time data is described by the following equation:
where dN(t)/dt is the rate of change in the number of bacterial cells over time, N(t) is the number of bacterial cells at time t, N max is the maximum number of bacteria after saturation in growth and K g max is the bacterial growth rate constant. Incorporating a time lag term into the model was attempted. The estimated in vitro growth rate for each of the isolates was compared with that of its parent wild-type isolate (when applicable) using Student's t-test. P values ,0.01 were considered significant unless otherwise stated.
In vitro competition experiments
The growth and survival of two MDR isolates were determined when each of the two isolates was grown in a co-culture with the wild-type strain PAO1. For this purpose, a 10 mL MHB flask was inoculated with approximately 10 6 exponentially growing cells of each of the two competing strains. The heterogeneous culture was incubated with continuous shaking at 378C for 12 h to complete one cycle of competition. Successive cycles of growth competition were made by transferring 10 mL from the competition flask to another 10 mL fresh MHB flask and further incubating for 12 h. Every 24 h (two competition cycles), three 500 mL samples were obtained from the competition flask to determine the number of cfu/mL for each isolate. The samples were serially diluted with 0.9% saline solution and 50 mL of the 10-fold dilutions were plated in parallel on antibiotic-free MHA plates and MHA plates containing 0.4 mg/L of levofloxacin. The MIC of levofloxacin was previously determined using the agar dilution method. The concentration of levofloxacin was chosen to selectively inhibit the growth of the wild-type strain PAO1 (MIC¼0.25 mg/L) and minimally affect the growth of PAO1DmexRDoprD and PA9019 (MICs ¼1.5 and .32 mg/L, respectively). The plates were incubated for 24 h at 358C and then colonies were counted. The number of cfu on the antibiotic-free plates was used to determine the total bacterial burden of both strains. The number of cfu on the levofloxacin-supplemented plates was used to determine the bacterial burden of the resistant strain. The bacterial burden of PAO1 was calculated by subtracting the number of cfu of the resistant strain from the total bacterial burden. Each competition experiment was run for 6 days.
Assessment of biofilm attachment
To rule out the possibility of bias (when transferring the cells between cycles) due to the excessive attachment of cells to the biofilm, the two isolates (PAO1DmexDoprD and PA9019) were compared with PAO1 using the MBEC TM high-throughput (HTP) assay (Innovotech, Edmonton, AB, Canada). 24 For this purpose, overnight cultures of the isolates were inoculated in 10 mL of MHB and incubated with continuous shaking at 378C. The cultures were diluted based on absorbance at 630 nm to an inoculum of approximately 10 5 cfu/mL in MHB. For each isolate, 22 mL of the diluted culture were added to the MBEC TM -HTP device. The three devices were placed on an incubating rocking platform shaker to assist the formation of biofilms on the polystyrene pegs. The shaker was set at 378C at a speed of 9 rpm and the tilt angle was 38. After 12 h, three pegs from each device were removed using sterile forceps. The pegs were rinsed with sterile saline to remove any loosely adherent planktonic cells from the biofilms. Each peg was transferred into a tube containing 1 mL of sterile saline. The tubes were sonicated for 15 min to disrupt the biofilms from the surface of the pegs into the saline. The biofilm suspensions were serially diluted and cultured quantitatively as described above. The biofilm attachment of each of the two isolates was compared with that of PAO1 using Student's t-test.
In vivo growth comparison
The in vivo growth of PAO1 was compared with that of PAO1DmexRDoprD using a murine pneumonia model. Approximately 3×10 6 exponentially growing cells of each isolate were washed with saline and inoculated into the trachea of seven anaesthetized mice under laryngoscopic guidance, as described previously. 25 Two mice from each group were sacrificed at baseline by CO 2 asphyxiation to ascertain the bacterial burden in the lungs. For this purpose, the lungs were collected aseptically and homogenized in 10 mL of sterile 0.9% saline. The homogenates were then centrifuged at 10000 g and 48C for 15 min. The supernatants were decanted and the pellets were reconstituted in sterile saline to 10× the original volume. The reconstituted suspensions were serially diluted and cultured quantitatively as described above. After 23 h, all the mice were sacrificed by CO 2 asphyxiation. The lungs of all the mice were collected and processed as outlined above. The bacterial burden was determined and the in vivo growth of the two strains was compared using Student's t-test.
Virulence in a murine pneumonia model
The impact of resistance mutations on the virulence of PAO1, PAO1D mexR, PAO1DoprD, PAO1DmexRDoprD, PA2599 and PA9019 was studied. Approximately 3×10 6 exponentially growing cells of each isolate were inoculated into the trachea of 13 anaesthetized mice under laryngoscopic guidance. Three mice were sacrificed at baseline to ascertain the bacterial burden in the lungs. The remaining 10 mice were monitored every 12 h for up to 10 days. Infected animals found moribund were euthanized by CO 2 asphyxiation and were counted as death observed at the following timepoint. All surviving mice were sacrificed at the end of the experiment. The lungs of all the mice were collected, either upon death or at the end of the experiment (for those that survived), and processed as outlined above. The mortality over time of each strain was compared with that of PAO1 using KaplanMeier survival analysis and log-rank test.
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Results
In vitro growth rates
Relative to the wild-type comparator strain, three out of eight drug-resistant isolates showed a slight reduction in growth rate when grown in full-strength MHB. When the isolates were grown in 0.25-strength MHB, a more significant extent of fitness reduction was observed, with four out of eight isolates showing a statistically significant reduction in growth rate (Table 1) . Incorporating a time lag term into the model did not appear to improve the data fit significantly (data not shown).
In vitro competition and biofilm assessment
In the first competition experiment, PAO1DmexRDoprD competed against its parent isolate PAO1. After two growth competitions (24 h), the bacterial burden (mean+SD) of PAO1DmexRDoprD was significantly reduced compared with that of PAO1 (8.57+0.017 log 10 cfu/mL versus 9.36+0.114 log 10 cfu/mL, respectively), as shown in Figure 1(a) . The relative proportion of the mutant isolate continued to decline with successive cycles. After 12 cycles (6 days), an approximately 10 000-fold difference in bacterial burden was observed. The relative fitness [calculated as the natural logarithm (ln) of the ratio of cfu/mL at the end of the competition to the initial cfu/mL] of PAO1 was found to be 11.1, whereas the relative fitness of PAO1DmexRDoprD was found to be 2.7. In the second competition experiment, the clinical strain PA9019 competed against the wild-type strain PAO1. As shown in Figure 1(b) , the resistant isolate was also out-competed by the wild-type strain, resulting in a .10 000-fold difference after only 6 cycles. The relative fitness of PAO1 was found to be 10.8, whereas the relative fitness of PA9019 was found to be 20.05. When the biofilm attachment of the three isolates was compared, no significant difference in the biofilm bacterial burden was detected (data not shown). Consistent with the growth rate findings, these data implied that the mutant strains had reduced fitness, which negatively impacted their ability to compete with the wild-type strain.
In vivo growth comparison
The baseline bacterial burdens in the lungs of the mice infected with PAO1 and PAO1DmexRDoprD were similar. After 23 h, a statistically significant difference in the tissue bacterial burden (mean+SD) with PAO1 (8.354+0.706 log 10 cfu/g) compared with PAO1DmexRDoprD (6.65+0.777 log 10 cfu/g) was detected (P ¼ 0.0067), as shown in Figure 2 . These data indicated that acquiring resistance mutations significantly reduced the in vivo growth rate of P. aeruginosa, consistent with the findings of the in vitro experiments.
Virulence in murine pneumonia model
There were important differences in the virulence of various resistant mutants tested (see Figure 3) . The wild-type strain PAO1 caused a relatively high rate of mortality, resulting in 0% survival within 48 h. Compared with PAO1, acquisition of a single resistance mechanism (in the cases of the PAO1DmexR and PAO1DoprD mutant strains) was associated with only limited reduction in mortality rates. However, PAO1DmexRDoprD (carrying both resistance mechanisms) demonstrated a dramatic reduction in mortality compared with PAO1 (P ¼ 0.0003), with 60% of the mice surviving until the end of the experiment. As for the clinical isolates, the results were somewhat unexpected. The mortality rate caused by PA9019 (a clinical MDR strain) was very high, resulting in 0% survival within 36 h. On the other hand, PA2599 (a clinical wild-type) showed a lower mortality rate compared with PAO1 (P ¼0.0046), with 30% of the mice surviving Abdelraouf et al.
until the end of the experiment. The bacterial burden in the lungs of all the mice was assessed. For all the mice that died before the end of the experiment, a heavy bacterial burden was found in lung tissues and most of them had an approximately 100-fold increase in cfu/g as compared with the baseline level, suggesting that pneumonia was the most likely cause of death. In contrast, the bacterial burden in lung tissues was lower than baseline in surviving mice (data not shown).
Discussion
Multidrug resistance of P. aeruginosa is a devastating problem in hospitals worldwide. 9 Increasing numbers of P. aeruginosa isolates resistant to the majority of the currently available antibiotics and causing serious infections are being recovered in clinical settings. 8, 20 Whether different resistance mutations are associated with a cost in pathogenicity of P. aeruginosa is not fully understood. Knowledge of the impact of resistance mutations on the fitness and the virulence of P. aeruginosa may help to design strategies that can minimize the spread of resistance. One strategy is to restrict the use of an antibiotic until the prevalence of the resistant isolates declines, assuming that the resistant isolates are less capable of competing with their susceptible counterparts co-existing in the environment in the absence of an antibiotic selective pressure. 26, 27 However, this strategy has been criticized. Avirulent resistant mutants of S. typhimurium have been shown to rapidly accumulate multiple compensatory mutations that restore virulence and fitness without loss of drug resistance. 11 Compensatory adaptation in P. aeruginosa has also been previously reported. 28 Alternatively, a possible antibiotic design strategy is to identify targets for which the resistance mechanism(s) would negatively impact the fitness of the bacterium. 29 Thus, even though the bacteria could acquire resistance, the overall proportion of resistant mutants might not rise in the population.
Recent studies have investigated the relationship between the acquisition of several antibiotic resistance mechanisms and their impact on the fitness and/or virulence of P. aeruginosa. Fitness and virulence of MDR P. aeruginosa 1315 JAC Kugelberg et al. 5 studied the effect of quinolone resistance (caused by mutations that alter the target genes) on bacterial fitness. They demonstrated that high-level resistance resulted in reduced mutant fitness due to decreased DNA supercoiling, and that compensatory mutations had the potential to increase mutant fitness by restoring supercoiling to normal levels. In another study, Montanari et al. 30 studied the biological cost of hypermutation due to the inactivation of the mismatch repair (MMR) system in P. aeruginosa strains isolated from cystic fibrosis patients. They showed that the increased mutagenesis due to MMR deficiency was associated with a significant biological cost, resulting in a reduced potential for the colonization of secondary environments and strain transmissibility. The impact of efflux pumps on the ability of P. aeruginosa to invade a monolayer of Madin-Darby canine kidney (MDCK) cells was investigated by Hirakata et al. 31 They found that mutants that lacked MexAB-OprM were not able to invade the monolayer. Invasion capability could be restored by complementation with MexAB-OprM or by supplementing the assay with culture supernatant from monolayer cells infected with wild-type P. aeruginosa. A possible explanation of these findings is that efflux pumps extrude not only antibiotics, but also virulence determinants such as adhesins, toxins and other proteins essential for colonization and invasion of the host cells. 32 On the other hand, over-expression of various Mex efflux pumps was associated with a reduction in the virulence of P. aeruginosa, possibly due to the increase in efflux of quorum-sensing molecules, resulting in impaired expression of virulence determinants regulated by these signals. 32, 33 In this study, the in vitro growth rates of different P. aeruginosa isolates were determined in full-strength MHB and under nutrient stress (in 0.25-strength MHB). Our rationale was that a reduction in growth rates of the mutant isolates (if any) would be more apparent when the isolates are grown under nutrient-limited conditions. 34 Consistent with previously published studies, different resistance mutations were associated with varying biological costs, often manifested as a reduction in growth rates. 35, 36 Accumulation of more than one resistance mutation did not seem to be associated with a further reduction in the growth rate of the isolates. In addition, we showed that the resistant mutants (PAO1DmexRDoprD and PA9019) were out-competed in vitro by the wild-type PAO1, indicating that acquisition of antibiotic resistance has a negative impact on the biological competitiveness of P. aeruginosa. This could be attributed (at least partially) to the relatively lower growth rates of the resistant isolates, resulting in a preferential accumulation of the wild-type strain. Since in vitro studies on the fitness of antibiotic-resistant bacteria do not necessarily correlate with the in vivo fitness of bacteria, we compared the in vivo growth of the resistant strain PAO1DmexR-DoprD with that of PAO1. Consistent with the results of the in vitro studies, PAO1DmexRDoprD showed significantly slower growth in vivo compared with PAO1, suggesting the absence of mutations that compensate for fitness defects in vivo. Collectively these findings support that multidrug resistance in P. aeruginosa is associated with a reduction in bacterial fitness.
Within the PAO1 lineage, the parent wild-type demonstrated the greatest virulence. Acquisition of one resistance mechanism, such as over-expression of MexB efflux pumps or deletion of the outer membrane protein OprD, resulted in mild attenuation of virulence. Acquisition of both resistance mechanisms, as in PAO1DmexRDoprD, resulted in a further reduction in virulence. These findings imply that acquisition of resistance mechanisms results in decreased virulence in P. aeruginosa in a cumulative fashion. This could also be attributed to a difference in the growth rates of the isolates; the relatively fast growth of PAO1 led to a more rapid increase in the bacterial burden in the lungs compared with those infected with the resistant strains. However, this explanation could not be extrapolated to the clinical P. aeruginosa strains. The slow-growing clinical MDR strain PA9019 exhibited the highest degree of virulence among all the P. aeruginosa isolates, whereas the relatively faster growing clinical wild-type strain PA2599 showed only a mild degree of virulence. The lack of direct correlation between the rate of growth and the degree of virulence of clinical isolates could be ascribed to the existence of other unknown mutations. In the clinical setting, MDR strains may partially or fully recover their virulence deficits by acquiring compensatory mutations. Moreover, multidrug resistance is not the only factor affecting the pathogenicity of P. aeruginosa. The ability of the bacteria to secrete virulence toxins also contributes to its pathogenicity. 37 P. aeruginosa can secrete toxins into the surrounding extracellular environment via type I and type II protein secretion systems. 38 Additionally, it is now known that nearly 100% of the clinical strains of P. aeruginosa have the ability to inject toxins directly into adjacent host cells via a third delivery system called the type III protein secretion system. 39 Knowledge of the resistance mechanisms of clinical isolates as well as the types of exoenzymes present would enable the development of a mechanistic framework that can help us predict the virulence of these isolates.
A limitation of the present study was that only one strain of mice was used to examine the virulence of the P. aeruginosa isolates. Gol'dberg et al. 40 proposed that variations could exist in the quantitative composition and functional activity of immune cells of different strains of mice. It is possible that various strains of mice might respond differently to infections due to an innate difference in complement systems. Studies on the impact of resistance mutations on the virulence of P. aeruginosa isolates in different strains of mice are ongoing.
In summary, our data suggest that specific resistance mechanisms are associated with a fitness cost in P. aeruginosa. Furthermore, accumulation of resistance mutations is associated with a reduction in virulence of P. aeruginosa. To our knowledge, our study provides the first evidence for the epistatic effect of resistance mutations on virulence. The impact of resistance mutations on the virulence of clinical isolates may not be as straightforward. Identifying the resistance mechanisms and the other virulence determinants of these isolates would likely be helpful.
